Finally, a drug offers hope for hypothalamic obesity
Setmelanotide is giving new hope to patients with acquired hypothalamic obesity, a group for whom no other treatment approach has proven effective.
Diabetes Day spotlights achievements, current investigations
The Vanderbilt DTRC includes 140 faculty members from 15 departments and three colleges or schools at Vanderbilt and Meharry Medical College who conduct basic, clinical and translational research…
Study links small pancreas size to faster progression to stage 3 Type 1 diabetes
The study findings, published in the journal Diabetes Care, suggest that pancreas imaging can have a benefit in tracking disease development and recruitment for preventive and therapeutic trials…
Arrojo e Drigo receives award for excellence in the field of islet research
Vanderbilt’s Rafael Arrojo e Drigo, PhD, recently received the inaugural Robert L. Sorenson Young Investigator Award from the Midwest Islet Club (MIC) in recognition of his research excellence and…